Procter & Gamble revises sales and EPS forecast as Q3 revenue falls short despite beating EPS estimates.
Procter & Gamble Cuts 2025 Outlook After Weak Q3 Sales

Procter & Gamble Lowers 2025 Projections Following Q1 Performance
Procter & Gamble (NYSE symbol PG) adjusted its forecast following a fiscal third-quarter performance that led to a 2% drop in its premarket stock value on Thursday morning trading session. The company managed to surpass earnings estimates however its revenue fell short of expectations indicating the struggles in consumer spending trends.
Adjusted earnings per share came in at $1.54 which slightly exceeded the anticipated $1.53 mark but the quarterly revenue stood at $19.78 billion as opposed to the expected $20.20 billion projected by analysts. Certain key sectors like Beauty, Grooming, Fabric & Home Care, and Baby Feminine & Family Care recorded decreases in sales figures while Health Care remained stable without showing any surprises.
Following the earnings report P&G scaled back its sales forecast to predict flat sales instead of the previously anticipated 2%–4% growth. The projection for core EPS growth was also adjusted downward to a range of 2%–4% down from the target of 6%.
Stock prices have dropped slightly by more than 1% since the beginning of the year. The updated advice indicates the increasing challenges faced by consumers such as expenses, new trends in demand, and limited household finances. This serves as an indication for traders to review their investments in essential goods.